Content Hub

+

ACC 2023: 5-year follow-up data from the COAPT™ trial

Presentation slide deck for ACC 2023 by Gregg Stone on the COAPT™ trial relating to the 5-year follow-up of transcatheter repair in HF patients with secondary mitral regurgitation.

Download

LEARN MORE:

MitraClip™

Related Resources

TRENDING TOPICS

Valvular Heart Disease Guidelines at a Glance

Explore the Latest VHD Guideline Updates for Mitral and Tricuspid Regurgitation

Immediate Relief. Durable Benefits

MitraClip™ TEER Delivers Durable MR Reduction and Long-Term Patient Benefits

Reduced HF Hospitalisation. Improved Quality of Life

MitraClip™ TEER Reduces HF Hospitalisations and Improves Patient Outcomes

Der Inhalt dieser Website richtet sich an medizinisches Fachpersonal in der EMEA mit entsprechender Produktregistrierung durch die Gesundheitsbehörde, mit Ausnahme derjenigen, die in Frankreich praktizieren, da einige der Inhalte nicht mit dem französischen Werbegesetz N°2011-2012 vom 29. Dezember 2011, Artikel 34, übereinstimmen. Klicken Sie auf OK, um zu bestätigen, dass Sie Angehöriger eines Gesundheitsberufs sind, um fortzufahren.

OK ablehnen

ACC 2023: 5-year follow-up data from the COAPT™ trial

Related Resources

TRENDING TOPICS

Valvular Heart Disease Guidelines at a Glance

Immediate Relief. Durable Benefits

Reduced HF Hospitalisation. Improved Quality of Life

CONNEXT

Procedural tip & tricks with Navitor across all valve sizes

Transcatheter Aortic Valves Implant

1-year VANTAGE TAVI outcomes in low/intermediate-risk patients

A Defining Moment Has To Start Somewhere. Why Not With You?

CONNEXT

Procedural tip & tricks with Navitor across all valve sizes

Transcatheter Aortic Valves Implant

Transcatheter tricuspid valve repair: Cases, tips and tricks

M-TEER: Best treatment strategies for FMR AND DMR